Clinical Trial Update: Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients [Phase 2]

View source ↗

Summary

Phase 2, single-group, open-label trial evaluating the efficacy and safety of roflumilast in patients with symptomatic bronchiectasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Symptomatic Bronchiectasis | Phase 2 | Status: UNKNOWN